Methotrexate therapy impacts on red cell distribution width and its predictive value for cardiovascular events in patients with rheumatoid arthritis

Table 1 Demographics and laboratory parameters at initial diagnosis of RA

	CV-Event		P
	Yes (n = 23)	No (n = 362)	P
Gender Female, n (%)	15 (65,2)	293 (80,9)	0,068
Age, mean (SD), years	74,1 (7,1)	61,8 (13,2)	< 0,001
Disease duration, mean (SD), years	23,7 (13,2)	14,1 (11,7)	0,002
RF positive, n (%)	17 (73,9)	268 (74)	0,990
ACPA positive, n (%)	18 (78,3)	279 (77,1)	0,896
RDW, mean (SD)	15,6 (0,78)	13,6 (1,28)	0,025

Demographics and laboratory parameters at initial diagnosis of RA according to a CV event during follow up, p values for statistical significances between the two groups are given by Mann Whitney U test, respectively cross tables, significance level at p level ≤ 0,05, SD standard deviation, n sample size, RF rheumatoid factor, ACPA anti citrullinated peptide antibodies, RDW red cell distribution width

ISSN: 2520-1026